Literature DB >> 9525666

Efficient expression and rapid purification of human T-cell leukemia virus type 1 protease.

Y S Ding1, S M Owen, R B Lal, R A Ikeda.   

Abstract

Human T-cell leukemia virus type 1 (HTLV-1) is an oncovirus that is clinically associated with adult T-cell leukemia. We report here the construction of a pET19-based expression clone containing HTLV-1 protease fused to a decahistidine-containing leader peptide. The recombinant protein is efficiently expressed in Escherichia coli, and the fusion protein can be easily purified by affinity chromatography. Active mature protease in yields in excess of 3 mg/liter of culture can then be obtained by a novel two-step refolding and autoprocessing procedure. The purified enzyme exhibited Km and Kcat, values of 0.3 mM and 0.143 sec(-1) at pH 5.3 and was inhibited by pepstatin A.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9525666      PMCID: PMC109825     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  14 in total

1.  Substrates and inhibitors of human T-cell leukemia virus type 1 (HTLV-1) proteinase.

Authors:  O Hrusková-Heidingsfeldová; I Bláha; J Urban; P Strop; I Pichová
Journal:  Leukemia       Date:  1997-04       Impact factor: 11.528

2.  Purification and characterization of human T-cell leukemia virus type I protease produced in Escherichia coli.

Authors:  M Kobayashi; Y Ohi; T Asano; T Hayakawa; K Kato; A Kakinuma; M Hatanaka
Journal:  FEBS Lett       Date:  1991-11-18       Impact factor: 4.124

3.  Families of aspartic peptidases, and those of unknown catalytic mechanism.

Authors:  N D Rawlings; A J Barrett
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

Review 4.  Identification, purification, and cell culture assays of retroviral proteases.

Authors:  K von der Helm; S Seelmeier; A Kisselev; H Nitschko
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

Review 5.  Use of steady state kinetic methods to elucidate the kinetic and chemical mechanisms of retroviral proteases.

Authors:  T D Meek; E J Rodriguez; T S Angeles
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

6.  Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.

Authors:  A Gessain; F Barin; J C Vernant; O Gout; L Maurs; A Calender; G de Thé
Journal:  Lancet       Date:  1985-08-24       Impact factor: 79.321

7.  In vivo cellular tropism of human T-lymphotropic virus type II is not restricted to CD8+ cells.

Authors:  R B Lal; S M Owen; D L Rudolph; C Dawson; H Prince
Journal:  Virology       Date:  1995-07-10       Impact factor: 3.616

8.  Kinetic studies of human immunodeficiency virus type 1 protease and its active-site hydrogen bond mutant A28S.

Authors:  E Ido; H P Han; F J Kezdy; J Tang
Journal:  J Biol Chem       Date:  1991-12-25       Impact factor: 5.157

9.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

10.  Spontaneous lymphocyte proliferation in human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infection: T-cell subset responses and their relationships to the presence of provirus and viral antigen production.

Authors:  H E Prince; J York; J Golding; S M Owen; R B Lal
Journal:  Clin Diagn Lab Immunol       Date:  1994-05
View more
  1 in total

1.  Antibody reactivity to heat shock protein 70 and inner ear-specific proteins in patients with idiopathic sensorineural hearing loss.

Authors:  A E Tebo; P Szankasi; T A Hillman; C M Litwin; H R Hill
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.